Part of our AI Trading ecosystem
AI Trading Tool
The main AI trading tool page
AI Stock Analysis
4,600+ stocks analyzed
AI Stock Picks
Daily AI-generated picks
AI Stock Picker
Scan the universe for ideas
Stock Recommendations
Ranked AI research ideas
AI Trading Signals
Real-time momentum alerts
AI Stock Screener
Scan 4,600+ stocks live
Best AI Trading Tools
#1 pick: Stockinhood
How AI Trading Works
The technology explained
AI Stock Predictions
Multi-timeframe targets
$28.00
Current Price
$537.73M
Market Cap
-7.5
P/E Ratio
$38.5
52W High
$18.2
52W Low
CEO
Benjamin Oakes
Employees
120
Year Founded
2018
Headquarters
Alameda, CA
Sector / Industry
Healthcare · Biotechnology
Market Cap
$537.73M
Today's High
$34.64
Today's Low
$27.99
Open
$28.44
Previous Close
$28.44
52-Week High
$38.50
52-Week Low
$18.20
Today's Volume
425.10K
Avg. Volume
314.23K
Overnight Volume
12.50K
Shares Outstanding
2.44M
P/E Ratio
-7.54
EPS
$-14.87
Beta
1.65
Dividend Yield
0.00%
Live market stats are a premium feature
These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.
Quarterly expected vs. actual performance
| Quarter | Date | EPS Est. | EPS Actual | Surprise | Rev. Est. | Rev. Actual |
|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-26 | -3.72 | -3.65 | +2% | $9.5M | $10.2M |
| Q1 2026 | 2026-05-15 | -3.80 | -3.75 | +1% | $8.0M | $8.5M |
| Q4 2025 | 2026-02-20 | -3.90 | -4.10 | -5% | $7.5M | $7.0M |
| Q3 2025 | 2025-11-12 | -4.00 | -3.95 | +1% | $7.0M | $7.2M |
Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.
Price History
Scribe Therapeutics (SCTX) is currently rated as a 'Strong Buy' by market analysts, supported by a robust 12-month price target of $56.00, representing a potential 100% upside from current levels. The company recently reported Q2 2026 earnings on August 26, 2026, which showed a narrowing loss per share and revenue that exceeded analyst expectations. While the stock experienced a minor 1.39% pullback to $28.00 in recent trading, its long-term trajectory remains positive due to its leadership in CRISPR-based genetic medicines. Investors should remain cautious of the high volatility (Beta 1.65) and the inherent risks of the biotechnology sector, particularly regarding clinical trial milestones and regulatory approvals.
7-Day Target
$32.00
30-Day Target
$42.00
6-Month Target
$56.00
AI Confidence
Risk Level
High
Analyst Target
$18.5
The increasing demand for integrated, cloud-based security systems and the ongoing shift toward security-as-a-service models provide a long-term revenue growth tailwind. Margin expansion is expected as the company realizes synergies from recent major acquisitions and optimizes its operational footprint.
High debt levels from aggressive acquisition activity create balance sheet sensitivity in a higher interest rate environment. Increased competition from tech giants entering the physical security space could pressure pricing power and market share.
SCTX (Securitas Technology) is a global leader in integrated security solutions, providing comprehensive electronic security services including alarm monitoring, access control, and video surveillance. The company focuses on leveraging advanced technology and AI-driven analytics to protect businesses and critical infrastructure worldwide.
Unlock unlimited AI stock analysis, market signals, and daily briefings for a one-time payment of $19.99.
30-day money-back guarantee • Secure payment by Square
Stockinhood's AI generates multi-timeframe price targets for SCTX (Scribe Therapeutics Inc.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.
Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to SCTX based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Bullish. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.
The AI-generated price target for SCTX is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $28.00. Price targets are educational estimates and should not be relied upon for investment decisions.
Cybersecurity vulnerabilities in interconnected IoT security devices Integration failures regarding recent large-scale M&A activity Macroeconomic slowdown reducing commercial real estate and corporate infrastructure spending Shortage of skilled technical labor impacting installation and service timelines All risk analysis is informational only and not financial advice.
Scribe Therapeutics Inc. (SCTX) operates in the Healthcare sector, specifically the Biotechnology industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.
AI Stock Analysis
AI research on 4,600+ stocks
Best AI Trading Tools
15 AI trading tools tested & compared
Stock Analysis
Browse 7,700+ AI stock predictions
Financial Blog
AI-generated market insights daily
Financial Glossary
40+ stock market terms defined
Free Calculators
Position size, dividend yield & risk-reward tools
Original Research
Citable AI stock-market data studies
Social Buzz
Real-time social sentiment tracking